Bechara, A. (2005). Risky business : emotion, decision-making, and addiction. In Le jeu dans tous ses états (57). Brussels: University of Iowa, Antoine Bechara.
Keywords: pathological gambling; decision making; emotion; self-control; impulsive behavior; brain damage
|
Bätscher, R., & Piller, M. (2003). Die Einbettung der KlientInnenzufriedenheit im Q-System. In Symposium QuaTheDA 2003 : KlientInnenzufriedenheit (11). Bern: General Consulting Network (GCN).
Keywords: addiction care; quality; quality control; client satisfaction; conference; Switzerland
|
Barton, E. D., Colwell, C., Ramos, J., Benson, J., Baily, J., & Dunn, W. (2002). Intranasal administration of naloxone by paramedics.. Denver Health Medical Center, Denver Health Paramedic Division; University of Utah Health Sciences Center, Division of Emergency Medicine.
Abstract: Naloxone is a medication that is frequently administered in the field by paramedics for suspected opioid overdoses. Most prehospital protocols, however, require this medication to be given to patients intravenously (i.v.) or intramuscularly (i.m.). Unfortunately, intravenous line placement may be problematic and time-consuming in chronic i.v. drug users. There may also be a delay in patient response to opioid reversal with i.m. absorption of naloxone. Additionally, routine use of needles in high-risk populations poses an increased risk of occupational blood exposures to paramedics. OBJECTIVE: To prospectively test the effectiveness of intranasal (i.n.) naloxone administration by paramedics. This preliminary report summarizes the first month’s experience in the city of Denver. METHODS: Naloxone was first administered to patients found unconscious in the field using a nasal mucosal atomizer device (MAD). Patients were then treated using standard prehospital protocols, which included i.v. line placement and medications, if they did not immediately respond to i.n. naloxone. Time to patient response was recorded. RESULTS: A total of 30 patients received i.n. naloxone in the field over a one-month period. Of these, 11 patients responded to either i.n. or i.v. naloxone. Ten (91%) patients responded to i.n. naloxone alone, with an average response time of 3.4 minutes. Seven patients (64%) did not require an i.v. in the field after response to i.n. naloxone. CONCLUSIONS: Intranasal naloxone may provide a safe, rapid, effective way to manage suspected opioid overdoses in the field. Use of this route may decrease paramedic exposures to blood-borne diseases. The addition of i.n. naloxone administration to prehospital protocols should be considered as an initial therapy for suspected opioid abusers.
Keywords: AOD use; opioids in any form; overdose treatment; naloxone; mucosal administration; emergency medical technician
|
Atasoy, S. (2004). Scientific research on harm reduction : a reference list compiled for the distinguished delegates of the forty-seventh session of the Commission on Narcotic Drugs, 15-22 March, 2004, Vienna, Austria. In Forty-seventh Session of the Commission on Narcotic Drugs (201). Vienna: Sevil Atasoy.
Keywords: harm reduction; research; biography; international area; conference
|
(2001). Invitation : 3ème conférence nationale sur la promotion de la santé “expériences pratiques et conséquences pour l'avenir”. In 3ème conférence nationale sur la promotion de la santé : expériences pratiques et conséquences pour l’avenir (16). Martigny: Fondation suisse pour la promotion de la santé.
Keywords: health promotion; prevention; education; continuing education; Switzerland; conference
|
Eckmann, F. (2003). QuaTheDA stationär : Vertrag und Planung 2003/04 : Stand der Zertifizierungen : Bedarf an Schulung = QuaTheDA résidentiel : Contrats et planification 2003/04 : Certifications: état des lieux, Besoins de formation. In Qualitätsplattform Kantone-Bund = Plate-forme qualité cantons-Confédération (13). Schweizerische Koordinationsstelle für stationäre Therapieangebote im Drogenbereich (KOSTE); Centrale de coordination nationale de l'offre de thérapies résidentielles pour les problèmes de drogues (COSTE).
Keywords: quality control; QuaTheDA; addiction care; inpatient care; certification; continuing education; Switzerland
|
Stamm, R. (2003). Présentation QuaThéDA+ 2003-2008. In Plate-forme qualité cantons-Confédération (12). Présentation QuaThéDA+ 03-08. Berne: Office fédéral de la santé publique (OFSP).
Keywords: quality control; QuaTheDA; addiction care; collaboration; continuing education; Switzerland; conference
|
Wiesendanger, E. (2003). IVSE : aktueller Stand und Verankerung der Qualitätsentwicklung. In Qualitätsplattform Kantone-Bund (6). Bern: Konferenz der kantonalen Sozialdirektoren (SODK).
Keywords: quality control; treatment and maintenance; addiction care; collaboration; financing; Switzerland; conference
|
Wiesendanger, E. (2003). CIIS : état actuel de la situation et ancrage de la qualité. In Plate-forme Qualité cantons-Confédération (6). Berne: Conférence des directeurs cantonaux des affaires sociales (CDAS).
Keywords: quality control; treatment and maintenance; addiction care; collaboration; financing; Switzerland; conference
|
Newman, R. G. (1987). Zur Frage der Anwendung von Methadon in Deutschland : Text eines Vortrags, der auf einem Kongress in Frankfurt, Bundesrepublik Deutschland, am 14. November 1987 gehalten wird. (24, Anhang). Frankfurt am Main.
Keywords: AOD dependence; AOD dependent; intravenous drug user; illicit drug; heroin; licit drug; alcohol; treatment and maintenance; methadone maintenance; ethics; social and economic cost of AOD; AOD effects and AODR problems; AODR disorder; communicable disease; HIV infection; Aids; AOD abstinence; international area; Germany; drug substitution therapy
|